RenovoRx, Inc. (RNXT)
1.275
0.00 (0.00%)
USD |
NASDAQ |
Oct 12, 14:12
RenovoRx Market Cap : 57.53M for Oct. 12, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 09, 2026 | 57.76M |
| October 08, 2026 | 60.01M |
| October 07, 2026 | 61.82M |
| October 06, 2026 | 62.72M |
| October 05, 2026 | 66.33M |
| October 02, 2026 | 71.29M |
| October 01, 2026 | 69.94M |
| September 30, 2026 | 70.39M |
| September 29, 2026 | 70.84M |
| September 28, 2026 | 69.94M |
| September 25, 2026 | 74.90M |
| September 24, 2026 | 75.80M |
| September 23, 2026 | 73.55M |
| September 22, 2026 | 76.71M |
| September 21, 2026 | 75.35M |
| September 18, 2026 | 76.26M |
| September 17, 2026 | 78.06M |
| September 16, 2026 | 69.94M |
| September 15, 2026 | 77.61M |
| September 14, 2026 | 76.26M |
| September 11, 2026 | 79.41M |
| September 10, 2026 | 79.87M |
| September 09, 2026 | 90.02M |
| September 08, 2026 | 99.27M |
| September 04, 2026 | 107.84M |
| Date | Value |
|---|---|
| September 03, 2026 | 106.94M |
| September 02, 2026 | 113.71M |
| September 01, 2026 | 95.21M |
| August 31, 2026 | 87.09M |
| August 28, 2026 | 75.35M |
| August 27, 2026 | 66.78M |
| August 26, 2026 | 67.23M |
| August 25, 2026 | 64.07M |
| August 24, 2026 | 56.40M |
| August 21, 2026 | 59.56M |
| August 20, 2026 | 59.56M |
| August 19, 2026 | 59.34M |
| August 18, 2026 | 52.79M |
| August 17, 2026 | 54.15M |
| August 14, 2026 | 63.17M |
| August 13, 2026 | 56.85M |
| August 12, 2026 | 50.54M |
| August 11, 2026 | 51.89M |
| August 10, 2026 | 52.34M |
| August 07, 2026 | 50.46M |
| August 06, 2026 | 51.81M |
| August 05, 2026 | 47.76M |
| August 04, 2026 | 46.85M |
| August 03, 2026 | 47.76M |
| July 31, 2026 | 43.17M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Enanta Pharmaceuticals, Inc. | 355.56M |
| Travere Therapeutics, Inc. | 4.966B |
| REGENXBIO, Inc. | 434.40M |
| Krystal Biotech, Inc. | 9.821B |
| ACADIA Pharmaceuticals, Inc. | 3.363B |
Market Cap Related Metrics
| PS Ratio | 25.58 |
| Price to Book Value | 6.407 |
| Price | 1.275 |
| Earnings Yield | -24.63% |